Question · asked by 1 review
New‐generation antidepressants vs placebo: Quality of life at post‐treatment Indexed by self‐report measures of quality of life or functional disability
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
New‐generation antidepressants vs placebo Functional disability and quality of life (post‐treatment score on self report scales) Different self report scales (SF‐36, SDS) · somatoform disorders in adults Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane Headline outcomes only | no estimate extracted | 2 studies · 163 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Pharmacological interventions for somatoform disorders in adults 2014 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.